Provided by Tiger Trade Technology Pte. Ltd.

CMS Energy Corp

77.05
+0.46000.60%
Post-market: 77.03-0.0200-0.03%16:24 EST
Volume:2.79M
Turnover:214.88M
Market Cap:23.61B
PE:21.86
High:77.37
Open:76.93
Low:76.79
Close:76.59
52wk High:77.37
52wk Low:67.71
Shares:306.42M
Float Shares:302.00M
Volume Ratio:0.72
T/O Rate:0.92%
Dividend:2.20
Dividend Rate:2.85%
EPS(TTM):3.52
EPS(LYR):3.52
ROE:10.86%
ROA:3.15%
PB:2.65
PE(LYR):21.86

Loading ...

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Feb 05

Assessing China Medical System Holdings (SEHK:867) Valuation After CMS D017 Clinical Trial Approval

Simply Wall St.
·
Feb 05

China Medical System Receives Regulatory Nod to Begin Trials of CMS-D017

MT Newswires Live
·
Feb 04

CapBridge partners with AIA Singapore to distribute tailored insurance solutions supporting wealth and legacy planning for High-Net-Worth clients

prnewswire
·
Feb 04

CMS (00867) Self-Developed Innovative Drug CMS-D017 Capsule Receives Clinical Trial Approval Notice for Complement-Mediated Kidney Diseases

Stock News
·
Feb 03

CMS Energy Is Maintained at Equal-Weight by Morgan Stanley

Dow Jones
·
Feb 03

CMS Energy price target raised to $75 from $74 at Morgan Stanley

TIPRANKS
·
Feb 02

CVS Health (CVS) Is Down 10.2% After Surprise CMS Medicare Advantage Rate Proposal - Has The Bull Case Changed?

Simply Wall St.
·
Jan 31

CMS (867.HK/8A8.SG): Ruxolitinib Phosphate Cream Obtained China NDA Approval, Becoming The First and Only Targeted Drug for Vitiligo in China

GlobeNewswire
·
Jan 30

Takeda Flags Vyvanse Hit, Lifts 2025 Profit Guidance On Cost Control

Benzinga
·
Jan 29

Earning Preview: CMS Energy Corp — revenue is expected to decrease by 13.48%, and institutional views are cautiously constructive

Earnings Agent
·
Jan 29

Vitasora Health Lifts Revenue and Billing Productivity as CMS Changes and New Funding Support U.S. Growth

TIPRANKS
·
Jan 29

CMS Energy Is Maintained at Buy by Jefferies

Dow Jones
·
Jan 29

Jefferies & Co Adjusts CMS Energy PT to $81 From $79, Maintains Buy Rating

MT Newswires Live
·
Jan 28

Astrana Health Stock Slide Presents An Attractive Entry Point: Analyst

Benzinga_recent_news
·
Jan 28

Medicare Targets 15 High-Profile Drugs In Third Price Negotiation Cycle

Benzinga
·
Jan 28

How CMS Energy’s Dual Push on Customer Aid and Clean Power (CMS) Has Changed Its Investment Story

Simply Wall St.
·
Jan 28

U.S. RESEARCH ROUNDUP- Boeing, Carvana, UnitedHealth

Reuters
·
Jan 28

Astrana Health: Market Overreaction to CMS Risk-Adjustment Proposal Creates a Buy Opportunity

TIPRANKS
·
Jan 28

Midday Fly By: CMS proposal sinks insurers, UnitedHealth reports mixed Q4

TIPRANKS
·
Jan 28